Literature DB >> 21397375

[Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study].

María Grau1, Roberto Elosua, Antonio Cabrera de León, María Jesús Guembe, José Miguel Baena-Díez, Tomás Vega Alonso, Francisco Javier Félix, Belén Zorrilla, Fernando Rigo, José Lapetra, Diana Gavrila, Antonio Segura, Héctor Sanz, Daniel Fernández-Bergés, Montserrat Fitó, Jaume Marrugat.   

Abstract

INTRODUCTION AND
OBJECTIVES: To estimate the prevalence of cardiovascular risk factors in individuals aged 35-74 years in 10 of Spain's autonomous communities and determine the geographic variation of cardiovascular risk factors distribution.
METHODS: Pooled analysis with individual data from 11 studies conducted in the first decade of the 21st century. The average response rate was 73%. Lipid profile (with laboratory cross-validation), glucose level, blood pressure, waist circumference, height, and weight were measured and standard questionnaires administered. Age-standardized prevalence of smoking, diabetes, hypertension, dyslipidemia, and obesity in the European population were calculated. Furthermore, the coefficient of variation between component studies was determined for the prevalence of each risk factor.
RESULTS: In total, 28,887 participants were included. The most prevalent cardiovascular risk factors were high blood pressure (47% in men, 39% in women), total cholesterol ≥ 250 mg/dL (43% and 40%, respectively), obesity (29% and 29%, respectively), tobacco use (33% and 21%, respectively), and diabetes (16% and 11%, respectively). Total cholesterol ≥ 190 and ≥ 250 mg/dL were the respective minimum and maximum coefficients of variation (7%-24% in men, 7%-26% in women). Average concordance in lipid measurements between laboratories was excellent.
CONCLUSIONS: Prevalence of high blood pressure, dyslipidemia, obesity, tobacco use and diabetes is high. Little variation was observed between autonomous communities in the population aged 35-74 years. However, presence of the most prevalent cardiovascular risk factors in the Canary Islands, Extremadura and Andalusia was greater than the mean of the 11 studies.
Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397375     DOI: 10.1016/j.recesp.2010.11.005

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  29 in total

1.  Cardiovascular risk factors, lifestyle, and social determinants: a cross-sectional population study.

Authors:  Luis Palomo; Francisco-Javier Félix-Redondo; Luis Lozano-Mera; José-Fernando Pérez-Castán; Daniel Fernández-Berges; Francisco Buitrago
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

2.  No evidence of morbidity compression in Spain: a time series study based on national hospitalization records.

Authors:  Stefan Walter; Hiram Beltrán-Sánchez; Enrique Regidor; Carlos Gomez-Martin; Jose Luis Del-Barrio; Angel Gil-de-Miguel; S V Subramanian; Ruth Gil-Prieto
Journal:  Int J Public Health       Date:  2016-05-27       Impact factor: 3.380

3.  Low mortality in the poorest areas of Spain: adults residing in provinces with lower per capita income have the lowest mortality.

Authors:  Enrique Regidor; Fernando Vallejo; Carolina Giráldez-García; Paloma Ortega; Juana M Santos; Paloma Astasio; Luis de la Fuente
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

4.  Cholesterol and cardiovascular disease in the elderly. Facts and gaps.

Authors:  Francisco J Félix-Redondo; Maria Grau; Daniel Fernández-Bergés
Journal:  Aging Dis       Date:  2013-03-01       Impact factor: 6.745

5.  Aragon workers' health study--design and cohort description.

Authors:  José A Casasnovas; Victor Alcaide; Fernando Civeira; Eliseo Guallar; Borja Ibañez; Jesús Jiménez Borreguero; Martin Laclaustra; Montserrat León; José Luis Peñalvo; José M Ordovás; Miguel Pocovi; Ginés Sanz; Valentín Fuster
Journal:  BMC Cardiovasc Disord       Date:  2012-06-19       Impact factor: 2.298

6.  Prevalence of obesity and associated cardiovascular risk: the DARIOS study.

Authors:  Francisco Javier Félix-Redondo; María Grau; José Miguel Baena-Díez; Irene R Dégano; Antonio Cabrera de León; Maria Jesús Guembe; María Teresa Alzamora; Tomás Vega-Alonso; Nicolás R Robles; Honorato Ortiz; Fernando Rigo; Eduardo Mayoral-Sanchez; Maria José Tormo; Antonio Segura-Fragoso; Daniel Fernández-Bergés
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

Review 7.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

8.  Effect of cardiovascular prevention strategies on incident coronary disease hospitalisation rates in Spain; an ecological time series analysis.

Authors:  María José Medrano; Enrique Alcalde-Cabero; Cristina Ortíz; Iñaki Galán
Journal:  BMJ Open       Date:  2014-02-17       Impact factor: 2.692

9.  Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.

Authors:  Pedro Tauler; Miquel Bennasar-Veny; Jose M Morales-Asencio; Angel A Lopez-Gonzalez; Teofila Vicente-Herrero; Joan De Pedro-Gomez; Vanessa Royo; Jordi Pericas-Beltran; Antoni Aguilo
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort.

Authors:  Maria Teresa Alzamora; Rosa Forés; Guillem Pera; Pere Torán; Antonio Heras; Marta Sorribes; Jose Miguel Baena-Diez; Magalí Urrea; Judit Alegre; María Viozquez; Carme Vela
Journal:  BMC Cardiovasc Disord       Date:  2013-12-17       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.